all report title image

Metabolomics is the systematic identification and quantitation of all metabolites in a given organism or biological sample. Nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS), provide the enhanced resolution, along with the powerful chemometric software, that allows the simultaneous determination and comparison of thousands of chemical entities, which has lead to an expansion of small molecule biochemistry studies in bacteria, plants, and mammals. Targeted and untargeted metabolomics service are the two major types of metabolomics services.

The global metabolomics services market is estimated to be valued at US$ 483.74 million in 2022 and is expected to exhibit a CAGR of 14.2% during the forecast period (2022-2030).

Figure 1. Global Metabolomics Services Market Share (%), by Service Type, 2022

Metabolomics Services  | Coherent Market Insights

 Global Metabolomics Services Market - Drivers

Adoption of inorganic growth strategies such as product launches by key market players is expected to drive the global metabolomics services market over the forecast period. For instance, in June 2021, Thermo Fisher Scientific Inc., a manufacturer of analytical instruments, announced that they had launched Orbitrap IQ-X Tribrid mass spectrometer which enables confident structure elucidation and unknown analytes identification. The wide range applications of Orbitrap IQ-X Tribrid mass spectrometer include metabolomics and lipidomics research, leachable impurities identification, and forensic toxicology.

CMI table icon

Metabolomics Services Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 483.74 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2030
Forecast Period 2022 to 2030 CAGR: 14.2% 2030 Value Projection: US$ 1,396.79 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Service Type: Targeted Metabolomics Service, Untargeted Metabolomics Service
  • By Technique: Detection Techniques (Nuclear Magnetic Resonance Spectroscopy (NMR), Mass Spectrometry (MS)), Separation Techniques (Gas Chromatography (GC), Capillary Electrophoresis (CE), Liquid Chromatography (LC), Others (Supercritical Fluid Chromatography, Ion Mobility Spectrometry, etc.))
  • By Application: Drug Assessment, Biomarker Discovery, Nutrigenomics, Clinical toxicology, Others (Crop Breeding, Disease Diagnosis, etc.)
  • By End User: Academics and Research Labs, Biotechnology and Pharmaceutical Companies, Diagnostic Laboratories
Companies covered:

Thermo Fisher Scientific Inc., Agilent Technologies, Inc., SCIEX (Danaher), Waters Corporation, Shimadzu Corporation, Bruker, Human Metabolome Technologies Inc., LECO Corporation, Biocrates life sciences AG, Metabolon, Inc., Metabolomic Technologies Inc., PerkinElmer Inc., Analytik Jena GmbH, Creative Proteomics, Vproteomics, DNA Xperts Private Limited, MS-OMICS, metaSysX, BASF SE, BGI, Afekta Technologies Ltd., Metware Biotechnology Co.,Ltd.

Growth Drivers:
  • Increasing adoption of inorganic strategies such as product launches by key market players 
Restraints & Challenges:
  • Various challenges associated with the metabolomics such as sample collection, processing, and laboratory analysis phases, etc.

Figure 2. Global Metabolomics Services Market Share (%), by Region, 2022

Metabolomics Services  | Coherent Market Insights

Global Metabolomics Services Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 can affect the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others are facing problems with the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a negative impact on the global metabolomics services market. For instance, in March 2021, according to the data published in article Nature, by using the application targeted and untargeted metabolomics with gas chromatography-mass spectrometry (GC-MS) and ultra-high-pressure liquid chromatography-mass spectrometry (UHPLC-MS) on plasma samples of patients were diagnosed with SARS-CoV-2 infection and compared to 27 ambulatory patients with flu-like symptoms, negative for COVID-19. Thus, 77 metabolites exhibited stage-dependent alterations in their plasma concentration. From these metabolites, 57 were increased in critical care patients and among 30 metabolites, 29 were higher and 1 lower in critical than in mild cases. 

Global Metabolomics Services Market: Key Developments

Increasing adoption of inorganic growth strategies such as product launches by key market players is expected to drive the global metabolomics services market growth over the forecast period. For instance, in June 2022, Shimadzu Corporation, a medical equipment company, announced that they had launched LCMS-2050 high-performance liquid chromatograph mass spectrometer, which is used to discover the presence or absence of impurities in the pharmaceutical and chemical fields, and for the confirmation of synthetic products and measurement of the amounts of ingredients in food products.

Global Metabolomics Services Market: Restraint

Various challenges associated with the metabolomics is expected to hinder the global metabolomics market over the forecast period. For instance, according to an article published in national library of medicine, in January 2019, challenges typically arise during the sample collection, processing, and laboratory analysis phases. The type of specimen, collection method, storage conditions, and profiling-related variables such as analytical batch can impact metabolomic profiles and add noise to the data.

Global Metabolomics Services Market - Key Players

Major players operating in the global metabolomics services market include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., SCIEX (Danaher), Waters Corporation, Shimadzu Corporation, Bruker, Human Metabolome Technologies Inc., LECO Corporation, Biocrates life sciences AG, Metabolon, Inc., Metabolomic Technologies Inc., PerkinElmer Inc., Analytik Jena GmbH, Creative Proteomics, Vproteomics, DNA Xperts Private Limited, MS-OMICS, metaSysX, BASF SE, BGI, Afekta Technologies Ltd., Metware Biotechnology Co.,Ltd.

Metabolomics is defined as the large scale study of all small molecules, commonly known as metabolites, within cells, biofluids, tissues or organisms. It is the study of substrates and products of metabolism. Metabolomics is an evolving field to comprehensively identify and quantify all endogenous and exogenous low-molecular-weight (<1 kDa) small metabolites in a biological system in a high-throughput manner which are influenced by both genetic and environmental factors, lifestyle factors, medication, and underlying disease. Collectively, these small molecules and their interactions within a biological system are known as the metabolome. The metabolome is downstream of the transcriptome and proteome and is considered to be complementary to genomics, transcriptomics, and proteomics. Metabolomics services include targeted and untargeted metabolomics services. Metabolomics has various applications in health and disease including drug assessment, biomarker discovery, nutrigenomics, clinical toxicology, crop breeding, etc. Mass spectrometry based metabolomics provides a useful approach for both identification of disease related metabolites in biofluids or tissue and also encompasses classification and characterization of disease or treatment-associated molecular patterns generated from metabolites.

Market Dynamics

Increasing adoption of inorganic strategies such as research collaboration, in order to provide metabolomics services by key market players is expected to drive the global metabolomics services market over the forecast period. For instance, in July 2021, Thermo Fisher Scientific Inc., a manufacturer of analytical instruments, announced that they had entered into a research collaboration with the University of California, Davis, to launch Center of Excellence in clinical metabolomics to develop new technologies and reproducible analytical techniques to support rapid, cost-effective clinical research into applications for metabolomics in precision medicine.

Key features of the study:

  • This report provides an in-depth analysis of the global metabolomics services market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global metabolomics services market based on the following parameters–company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., SCIEX (Danaher), Waters Corporation, Shimadzu Corporation, Bruker, Human Metabolome Technologies Inc., LECO Corporation, Biocrates life sciences AG, Metabolon, Inc., Metabolomic Technologies Inc., PerkinElmer Inc., Analytik Jena GmbH, Creative Proteomics, Vproteomics, DNA Xperts Private Limited, MS-OMICS, metaSysX, BASF SE, BGI, Afekta Technologies Ltd., Metware Biotechnology Co.,Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global metabolomics services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global metabolomics services market

Detailed Segmentation:

  • Global Metabolomics Services Market, By Service Type:
    • Targeted Metabolomics Service
    • Untargeted Metabolomics Service
  • Global Metabolomics Services Market, By Technique:
    • Detection Techniques
      • Nuclear Magnetic Resonance Spectroscopy (NMR)
      • Mass Spectrometry (MS)
    • Separation Techniques
      • Gas Chromatography (GC)
      • Capillary Electrophoresis (CE)
      • Liquid Chromatography (LC)
      • Others (Supercritical Fluid Chromatography, Ion Mobility Spectrometry, etc.)
  • Global Metabolomics Services Market, By Application:
    • Drug Assessment
    • Biomarker Discovery
    • Nutrigenomics
    • Clinical toxicology
    • Others (Crop Breeding, Disease Diagnosis, etc.)
  • Global Metabolomics Services Market, By End User:
    • Academics and Research Labs
    • Biotechnology and Pharmaceutical Companies
    • Diagnostic Laboratories
  • Global Metabolomics Services Market, By Region:
    • North America
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Regions
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Thermo Fisher Scientific Inc.*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Agilent Technologies, Inc.
    • SCIEX (Danaher)
    • Waters Corporation
    • Shimadzu Corporation
    • Bruker
    • Human Metabolome Technologies Inc.
    • LECO Corporation
    • Biocrates life sciences AG
    • Metabolon, Inc.
    • Metabolomic Technologies Inc.
    • PerkinElmer Inc.
    • Analytik Jena GmbH
    • Creative Proteomics
    • Vproteomics
    • DNA Xperts Private Limited
    • MS-OMICS
    • metaSysX
    • BASF SE
    • BGI
    • Afekta Technologies Ltd.
    • Metware Biotechnology Co.,Ltd.

 “*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The global metabolomics services market is estimated to be valued at US$ 483.74 million in 2022 and is expected to exhibit a CAGR of 14.2% between 2022 and 2030.
Factors such as increasing adoption of inorganic growth strategies such as product launches by key market players are expected to drive the market growth.
Untargeted metabolomics service is the leading service type segment in the market
Various challenges associated with the metabolomicssuch as sample collection, processing, and laboratory analysis phases, etc. is expected to hamper the market.
Major players operating in the market include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., SCIEX (Danaher), Waters Corporation, Shimadzu Corporation, Bruker, Human Metabolome Technologies Inc., LECO Corporation, Biocrates life sciences AG, Metabolon, Inc., Metabolomic Technologies Inc., PerkinElmer Inc., Analytik Jena GmbH, Creative Proteomics, Vproteomics, DNA Xperts Private Limited, MS-OMICS, metaSysX, BASF SE, BGI, Afekta Technologies Ltd., Metware Biotechnology Co.,Ltd. 

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo